Distribution and functional analysis of memory antiviral CD8 T cell responses in HIV-1 and cytomegalovirus infections

European Journal of Immunology

Volumn 32, Issue 12, 2002, Pages 3756-3764

  Ellefsen, Kim ^a   Harari, Alexander ^a   Champagne, Patrick ^b   Bart, Pierre Alexandre ^a   Sékaly, Rafick Pierre ^b   Pantaleo, Giuseppe ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Antiviral response; Cytomegalovirus; HIV 1; Memory CD8 T cell

Indexed keywords

CD45 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR7; GAMMA INTERFERON;

ANTIGEN SPECIFICITY; ANTIVIRAL ACTIVITY; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; EFFECTOR CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPH NODE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOID TISSUE; MEMORY CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE SUBPOPULATION; TARGET ORGAN;

EID: 0036919199     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200212)32:12<3756::AID-IMMU3756>3.0.CO;2-E     Document Type: Article

References (29)

1. Sallusto, F., Mackay, C. R. and Lanzavecchia, A., Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999. 401: 708-712.
2. Reinhardt, R. L., Khoruts, A., Merica, R., Zell, T. and Jenkins M. K., Visualizing the generation of memory CD4 T cells in the whole body. Nature 2001. 410:101-105.
3. Masopust, D., Vezys, V., Marzo, A. L. and Lefrancois, L., Preferential localization of effector memory cells in nonlymphoid tissue. Science 2001. 291: 2413-2417.
4. Champagne, P., Ogg, G. S., King, A. S., Knabenhans, C., Ellefsen, K., Nobile, M., Appay, V., Rizzardi, G. P., Fleury, S., Lipp, M., Förster, R., Rowland-Jones, S., Sékaly, R.-P., McMichael, A. J. and Pantaleo, G., Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 2001. 410: 106-111.
5. Emery, V. C., Investigation of CIVIV disease in immunocompromised patients. J. Clin. Pathol. 2001. 54: 84-88.
6. Klein, M. R., van Baalen, C. A., Holwerda, A. M., Kerkhof Garde, S. R., Bende, R. J., Keet, I. P., Eeftinck-Schattenkerk, J. K., Osterhaus, A. D., Schuitemarker, H. and Miedema, F., Kinetics of Gag-specific cytotoxic T lymphocyte responses dur ing the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J. Exp. Med. 1995.181:1365-1372.
7. Walker, B. D., Chakrabarti, S., Moss, B., Paradis, T. J., Flynn, T., Durno, A. G., Blumberg, R. S., Kaplan, J. C., Hisch, M. S. and Schooley, R. T., HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature 1987. 328: 345-348.
8. Ogg, G. S., Jin, X., Bonhoeffer, S., Dunbar, P. R., Nowak, M. A., Monard, S., Segal, J. P., Cao, Y., Rowland-Jones, S. L., Cerundolo, V., Hurley, A., Markowitz, M., Ho, D. D., Nixon, D. F. and McMichael, A. J., Quantitation of HIV-1 -specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 1998. 279: 2103-2106.
9. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 1994. 68: 6103-6110.
10. Koup, R. A., Safrit, J. T., Cao, Y., Andrews, C. A., McLeod, G., Borkowsky, W., Farthing, C. and Ho, D. D., Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 1994. 68: 4650-4655.
11. Bart, P. A., Rizzardi, G. P., Tambussi, G., Chavre, J. P., Chapuis, A. G., Graziosi, C., Corpataux, J. M., Halkic, N., Meuwly, J. Y., Munoz, M., Meylan, P., Spreen, W., McDade, H., Yerly, S., Perrin, L., Lazzarin, A. and Pantaleo, G., Immunological and virological responses in HIV-1-infected adults at early stage of established infection treated with highly active antiretroviral therapy. AIDS 2000. 14: 1887-1897.
12. Rizzardi, G. P., Tambussi, G., Bart, P. A., Chapuis, A. G., Lazzarin, A. and Pantaleo, G., Virological and immunological responses to HAART in asymptomatic therapy-naïve HIV-1 infected subjects according to CD4 count. AIDS 2000. 15: 2257-2263.
13. + T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression. Nat. Med. 1999. 5: 518-525.
14. + T cell responses associated with control of viremia. Science 1997. 278:1447-1450.
15. McMichael, A. J. and Rowland-Jones, S. L., Cellular immune responses to HIV. Nature 2001. 410. 980-987.
16. + lymphocytes. Science 1999. 283: 857-860.
17. + T cell depletion in simian immunodeficiency virus-infected macaques. J. Exp. Med. 1999. 189:991-998.
18. + T cell responses in human immunodeficiency virus type 1 -infected patients wir T cell counts and recurrent retinitis. J. Infect. Dis. 2001. 183:1285-1289.
19. + T cell responses to CMV in HIV-1 infected subjects. Virology 2001. 279:459-470.
20. Swain, S. L., Hu, H. and Huston, G., Class II-independent generation of CD4 memory T cells from effectors. Science 1999. 286: 1381-1383.
21. Murali-Krishna, K., Lau, L. L., Sambhara, S., Lemonnier, F. Altman, J. and Ahmen, R., Persistence of memory VD8 T cells in MHC Class I-deficient mice. Science 1999. 286:1377-1381.
22. + T cells vary in differentiation phenotype in different persistent virus infections. Nat. Med. 2002. 8: 379-385.
23. Kuroda, M. J., Schmitz, J. E., Charini, W. A., Nickerson, C. E., Lord, C. I., Forman, M. A. and Letvin, N. L., Comparative analysis of cytotoxic T lymphocytes in lymph nodes and peripheral blood of simian immunodeficiency virus-infected rhesus monkeys. J. Virol. 1999. 73:1573-1579.
24. + T cells during supervised treatment interruptions in chronic HIV-1 infection. J. Clin. Invest. 2002. 109: 837-843.
25. Pantaleo, G., Soudeyns, H., Demarest, J. F., Vaccarezza, M., Graziosi, C., Paolucci, S., Daucher, M. B., Cohen, O. J., Denis, F., Biddison, W. E., Sékaly, R. P. and Fauci, A. S., Accumulation of human immunodeficiency virus-specific cytotoxic T lymphocytes away from the predominant site of virus replication during primary infection. Eur. J. Immunol. 1997. 27: 3166-3173.
26. Pantaleo, G., Graziosi, C., Demarest, J. F., Butini, L., Montroni M., Fox, C. H., Orenstein, J. M., Kotier, D. P. and Fauci, A. S., HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993. 362: 355-358.
27. Gamadia, L. E., ten Berge, I. J. M., Picker, L. J. and van Lier, A. W., Skewed maturation of virus-specific CTLs? Nat. Immunol. 2002.3:203.
28. Altman, J. D., Moss, P. A., Goulder, R J., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMicheal, A. J. and Davis, M. M., Phenotypic analysis of antigen-specific T lymphocytes Science 1998. 274: 94-96.
29. Pantaleo, G., Graziosi, C., Butini, L., Pizzo, P.A., Schnittman, S. M., Kotler, D. P. and Fauci, A. S., Lymphoid organs function a, major reservoirs for human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 1991. 88: 9838-9842.